73233 Treatment of Plaque Psoriasis Involving High-Impact Sites With Icotrokinra, a Targeted Oral Peptide: Pooled Analyses of 4 Phase 3 Placebo-Controlled Trials
Journal of the American Academy of Dermatology · 2026-07 · 95 (1) · AB457
DOI: 10.1016/j.jaad.2026.04.1817 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Academy of Dermatology, 2026-07. Verfasst von Jennifer Soung und 10 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Soung, J., Armstrong, A. W., Vender, R. B., Riera-Monroig, J., Sebastian, M., Reyes-Servin, O., Edem, B. E., Hsu, M., Li, S., Yang, Y., & Gold, L. S. (2026). 73233 Treatment of Plaque Psoriasis Involving High-Impact Sites With Icotrokinra, a Targeted Oral Peptide: Pooled Analyses of 4 Phase 3 Placebo-Controlled Trials. Journal of the American Academy of Dermatology, 95(1), AB457. https://doi.org/10.1016/j.jaad.2026.04.1817
Vancouver
Soung J, Armstrong AW, Vender RB, Riera-Monroig J, Sebastian M, Reyes-Servin O, et al. 73233 Treatment of Plaque Psoriasis Involving High-Impact Sites With Icotrokinra, a Targeted Oral Peptide: Pooled Analyses of 4 Phase 3 Placebo-Controlled Trials. Journal of the American Academy of Dermatology. 2026;95(1):AB457. doi:10.1016/j.jaad.2026.04.1817
BibTeX
@article{Soung2026,
author = {Soung, Jennifer and Armstrong, April W. and Vender, Ronald B. and Riera-Monroig, Josep and Sebastian, Michael and Reyes-Servin, Ofelia and Edem, Bassey Effiom and Hsu, Ming-Chun and Li, Shu and Yang, Ya-Wen and Gold, Linda Stein},
title = {73233 Treatment of Plaque Psoriasis Involving High-Impact Sites With Icotrokinra, a Targeted Oral Peptide: Pooled Analyses of 4 Phase 3 Placebo-Controlled Trials},
journal = {Journal of the American Academy of Dermatology},
year = {2026},
volume = {95},
number = {1},
pages = {AB457},
doi = {10.1016/j.jaad.2026.04.1817}
}
EUVIMED